HAISCO PHARMACEUTI revenue breakdown overview

HAISCO PHARMACEUTI revenue for the last year amounted to 3.35 B CNY, the most of which — 849.67 M CNY — came from its highest performing source at the moment, Anesthesia, the year earlier bringing 437.18 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought HAISCO PHARMACEUTI 3.36 B CNY, and the year before that — 3.02 B CNY.